• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, INC VITEK® 2 GRAM-POSITIVE IDENTIFICATION ID TEST KIT; VITEK® 2 GP ID TEST CARD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, INC VITEK® 2 GRAM-POSITIVE IDENTIFICATION ID TEST KIT; VITEK® 2 GP ID TEST CARD Back to Search Results
Catalog Number 21342
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
Device not returned to manufacturer.
 
Event Description
A customer from the united states reported to biomérieux an identification issue in association with the vitek® 2 gp test kit.The customer reported having misidentifications of staphylococcus epidermidis.The customer stated the organism is a coagulase negative staphylococcus and mostly staphylococcus epidermidis.The vitek® 2 gp id test results indicated multiple coagulase negative staphylococcus species.The expected result was staphylococcus epidermidis.The customer tested the samples using a microscan instrument and the results were staphylococcus epidermidis.The customer stated that there was a delay in reporting results when samples are run on microscan, as this testing takes two (2) days to complete.There is no indication or report from the hospital or treating physician to biomérieux that the discrepant results led to any adverse event related to a patient's state of health.The test reports and isolates were requested from the customer.An internal biomérieux investigation has been initiated.
 
Manufacturer Narrative
A customer from the united states reported to biomérieux an identification issues with staphylococcus epidermidis in association with the vitek® 2 gp test kit.An investigation was conducted.The customer submitted four (4) strains and gp cards from the lot in question, along with gp cards from a different lot that was performing as expected.All four (4) strains were tested on the two card lots returned from the customer, retained cards of the same two lots returned, and one random lot.Therefore, a total of five (5) cards were tested per isolate.Api staph was also performed.Isolate 911279 (40197056039): four of the cards tested gave low discrimination calls of s.Epidermidis / s.Hominis ssp hominis.The fifth card gave an excellent id (97%) of s.Epidermidis.Api staph also gave a good id (94.3%) of s.Epidermidis.Therefore, the final identification is s.Epidermidis.Since the low discrimination call includes the correct call of s.Epidermidis, all cards are performing as expected.Isolate 911280 (40196905288): on all 5 cards tested, a very good id (95%) of s.Epidermidis was obtained.Api staph gave a very good id to the genus of staphylococcus: s.Epidermidis (88.5%) / s.Capitis (7%) /s.Haemolyticus (2%) / s.Hominis (2%).Isolate 911281 (40197163130): four of the cards tested gave very good (94%) or excellent (96%) id of s.Warneri.One card gave a low discrimination call of s.Warneri/s.Epidermidis/s.Hominis ssp hominis.Api staph gave a good id (94%) of s.Warneri.Therefore, the final identification is s.Warneri.Since the low discrimination call includes the correct call of s.Warneri, all cards are performing as expected.Isolate 911286 (40196960368): four of the cards tested gave an excellent id (99%) of s.Epidermidis.One card gave a low discrimination call of s.Epidermidis / s.Hominis ssp hominis.Api staph also gave a good id (90.2%) of s.Epidermidis.Therefore, the final identification is s.Epidermidis.Since the low discrimination call includes the correct call of s.Epidermidis, all cards are performing as expected.A comparison of customer reaction results for the cards giving the misidentification of s.Lugdunensis against expected reaction results for s.Epidermidis revealed one (1) atypical negative reaction (ure).A comparison of customer reaction results for the cards giving the misidentification of s.Hominis ssp hominis against expected reaction results for s.Epidermidis revealed four (4) atypical negative reactions (adh1, dmal, baci, o192r).The investigation concluded the vitek® 2 gp cards are performing as expected and no further action is necessary.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® 2 GRAM-POSITIVE IDENTIFICATION ID TEST KIT
Type of Device
VITEK® 2 GP ID TEST CARD
Manufacturer (Section D)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer (Section G)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer Contact
ellen weltmer
595 anglum road
st. louis, MO 63042
3147317301
MDR Report Key6296044
MDR Text Key66361541
Report Number1950204-2017-00041
Device Sequence Number1
Product Code LQL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K952095
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 03/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/02/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/20/2017
Device Catalogue Number21342
Device Lot Number2420024103
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/28/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/20/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-